AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amanta Healthcare Limited reported audited financial results for FY2026 with revenue from operations of Rs. 28,767.67 lakhs, up 4.7% from Rs. 27,470.82 lakhs in FY2025. Profit after tax grew significantly by 41.7% to Rs. 1,487.52 lakhs from Rs. 1,050.07 lakhs. EPS improved to Rs. 4.33 from Rs. 3.71. The company completed its IPO on NSE in September 2025, raising Rs. 12,600 lakhs; Rs. 7,353.25 lakhs has been utilized so far primarily for capital expenditure on new manufacturing lines at Hariyala, Kheda. Cash position improved dramatically to Rs. 8,101.03 lakhs from Rs. 22.06 lakhs. Finance costs increased substantially to Rs. 2,074.57 lakhs due to new borrowings. The Board also approved amendments to the Insider Trading Code and Whistle Blower Policy. Statutory auditors issued an unmodified opinion.
Strong profit growth of 42% YoY indicates operational efficiency improvement. However, the high finance costs and significant debt levels warrant monitoring. The IPO proceeds deployment for capacity expansion could drive future revenue growth.